You are here

Home

Clinical Trials: Lung Disease

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Wednesday, January 18, 2023 - 12:00
UC-MSCs in the Treatment of Severe and Critical COVID-19 Patients With Refractory Hypoxia
Conditions:   Mesenchymal Stem Cell;   COVID-19 Pneumonia
Intervention:   Biological: UC-MSCs treatment
Sponsors:   Shanghai East Hospital;   Sir Run Run Shaw Hospital
Recruiting
Posted: Thursday, January 12, 2023 - 12:00
UC-MSCs in the Treatment of Severe and Critical COVID-19 Patients
Conditions:   Mesenchymal Stem Cell;   COVID-19 Pneumonia
Interventions:   Biological: umbilical cord mesenchymal stem cells;   Drug: paxlovid
Sponsor:   Shanghai East Hospital
Recruiting
Posted: Friday, December 9, 2022 - 12:00
Zofin to Treat Chronic Obstructive Pulmonary Disease (COPD)
Condition:   COPD
Interventions:   Drug: Zofin;   Other: Placebo
Sponsor:   Organicell Regenerative Medicine
Recruiting
Posted: Tuesday, November 15, 2022 - 12:00
Modeling Bronchial Epithelium in Severe Asthma With Human Induced Pluripotent Stem Cells (iPSC)
Conditions:   Severe Asthma;   Allergic Bronchopulmonary Aspergillosis (ABPA)
Intervention:   Other: Blood sample
Sponsor:   University Hospital, Montpellier
Not yet recruiting
Posted: Wednesday, October 26, 2022 - 12:00
COPD Treatment by Transpantation of Autologous Bronchial Basal Cells
Condition:   Chronic Obstructive Pulmonary Disease (COPD)
Intervention:   Biological: Autologuos transplantation of bronchial basal cells
Sponsors:   Guangzhou Institute of Respiratory Disease;   Regend Therapeutics
Recruiting
Posted: Thursday, August 11, 2022 - 12:00
A Controlled Study to Evaluate the Efficacy of Allogeneic MesenCure for the Treatment of Patients With COVID-related Pneumonia
Condition:   Covid-related Pneumonia
Interventions:   Biological: MesenCure;   Other: Placebo
Sponsor:   BonusBio Group Ltd
Not yet recruiting
Posted: Monday, August 8, 2022 - 12:00
AllogeneiC Expanded Human Mesenchymal Stem Cell Therapy in Patients Recovering From COVID-19 Acute Respiratory Distress (ACE CARD) Trial
Condition:   ARDS, Human
Intervention:   Biological: intravenous delivery of allogeneic bone marrow-derived MSCs
Sponsor:   BioCardia, Inc.
Not yet recruiting
Posted: Tuesday, May 24, 2022 - 12:00
Safety and Effectiveness of Placental Derived Exosomes and Umbilical Cord Mesenchymal Stem Cells in Moderate to Severe Acute Respiratory Distress Syndrome (ARDS) Associated With the Novel Corona Virus Infection (COVID-19)
Conditions:   COVID-19 Acute Respiratory Distress Syndrome;   Respiratory Distress Syndrome
Interventions:   Drug: EV-Pure™ and WJ-Pure™;   Drug: Placebo
Sponsor:   Vitti Labs, LLC
Recruiting
Posted: Friday, April 29, 2022 - 12:00
Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles as Early Goal Directed Therapy for COVID-19 Moderate-to-Severe Acute Respiratory Distress Syndrome (ARDS): A Phase III Clinical Trial
Condition:   COVID-19 Acute Respiratory Distress Syndrome
Intervention:   Drug: EXOFLO
Sponsor:   Direct Biologics, LLC
Not yet recruiting
Posted: Wednesday, April 27, 2022 - 12:00
A First-In-Human Phase 1b Study of AmnioPul-02 in COVID-19
Condition:   COVID-19
Intervention:   Drug: AmnioPul-02
Sponsor:   Amniotics AB
Not yet recruiting

Pages